Diligence memo · auto-generated · as of July 2, 2026

ImmunSYS, Inc.

ImmunSYS, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

ImmunSYS, Inc. operates in Other Health Care, based in Fort Lauderdale.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

ImmunSYS, Inc. has raised $960K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $5.2M on 2018-08-07.

Most recent recorded round closed around 2020-04-15.

Valuation (modeled)modeled

Provath models ImmunSYS, Inc. at approximately $8.7M (range $178K–$99M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.08× the median modeled value of Pre-Seed Other Health Care companies in 2019–2021 (295 peers) — value vs value, same stage and era. Within the normal band (108% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 10 months.

Last raise 6.2 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 2.4× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 32% of Other Health Care peers (5377 compared).

Modeled value ranks above 32% of those peers.

Closest niche peers: Aetas Co LLC, Hauppauge SC Holdings, LLC, Gateway IV Lithotripsy, LLC, Endoscopy Center of West Central Ohio, LLC, Dalent LLC.

Peoplefiled

13 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.